60 DEGREES PHARMACEUTICALS, INC. Long-Term Debt, Maturity, Year Five
60 DEGREES PHARMACEUTICALS, INC. (SXTP) had Long-Term Debt, Maturity, Year Five of $3.61 thousand as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2026-03-30
- 2025-12-31: Long-Term Debt, Maturity, Year Five $3.61K.
- 2024-12-31: Long-Term Debt, Maturity, Year Five $3.47K.
- 2024-09-30: Long-Term Debt, Maturity, Year Five $142.75K.
- 2024-03-31: Long-Term Debt, Maturity, Year Five $142.75K.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2025-12-31 | $3.61K 10-K · filed 2026-03-30 |
| 2024-12-31 | $3.47K 10-K · filed 2025-03-27 |
| 2024-09-30 | $142.75K 10-Q · filed 2024-11-14 |
| 2024-03-31 | $142.75K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $3.34K 10-K · filed 2024-04-01 |
| 2023-09-30 | $147.20K 10-Q · filed 2023-11-20 |
| 2023-06-30 | $147.20K 10-Q · filed 2023-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |